---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-081995"
form_type: "8-K"
ticker: "IMRX"
cik: "0001790340"
company_name: "Immuneering Corp"
filed_at: "2025-08-25T23:59:59+00:00"
generated_at: "2026-05-17T10:16:32.133275+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Immuneering raises $25M in private placement at $3.95/unit, warrants at $5.50

## Summary
- $25M gross proceeds from 6.33M shares (or pre-funded warrants) and 2.85M warrants at $5.50.
- Combined purchase price of $3.95 per unit, representing a ~15% premium over Aug. 20 close.
- Proceeds to support clinical development of atebimetinib in first-line pancreatic cancer.
- Closing expected on or about August 26, 2025; registration rights agreement filed.

## SEC filing metadata
- accession: 0001104659-25-081995
- form_type: 8-K
- ticker: IMRX
- cik: 0001790340
- company_name: Immuneering Corp
- filed_at: 2025-08-25T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/0001104659-25-081995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790340/000110465925081995/tm2524079d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-081995
- JSON: https://secwatch.observer/filing/0001104659-25-081995.json
- Plain text: https://secwatch.observer/filing/0001104659-25-081995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.